Primary Site >> Colorectal Cancer
Gene >> SETBP1
| 1. | |||||||||||
| Journal: | Eur J Immunol. 1991 May;21(5):1229-33. | ||||||||||
| Title: | Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor. | ||||||||||
| Author: | Dohlsten, M|Hedlund, G|Segren, S|Lando, P A|Herrmann, T|Kelly, A P|Kalland, T | ||||||||||
| PMID: | 1645269 | ||||||||||
| 2. | |||||||||||
| Journal: | Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9287-91. | ||||||||||
| Title: | Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents. | ||||||||||
| Author: | Dohlsten, M|Hedlund, G|Akerblom, E|Lando, P A|Kalland, T | ||||||||||
| PMID: | 1924393 | ||||||||||
| 3. | |||||||||||
| Journal: | Immunol Lett. 1992 Dec;34(3):229-36. | ||||||||||
| Title: | Locally superantigen-activated peritoneal cytolytic T lymphocytes belong to the CD8+ CD45RC- subset and lyse MHC class II+ tumor cells. | ||||||||||
| Author: | Hansson, J|Ericsson, P O|Dohlsten, M|Sjogren, H O|Kalland, T|Hedlund, G | ||||||||||
| PMID: | 1487309 | ||||||||||
| 4. | |||||||||||
| Journal: | Cancer Immunol Immunother. 1995 Sep;41(3):193-8. | ||||||||||
| Title: | The immunomodulatory effect of levamisole is influenced by postoperative changes and type of lymphocyte stimulant. | ||||||||||
| Author: | Abdalla, E E|Adam, I J|Blair, G E|Boylston, A|Sue-Ling, H M|Finan, P|Johnston, D | ||||||||||
| PMID: | 7553689 | ||||||||||
| 5. | |||||||||||
| Journal: | Cancer Immunol Immunother. 1995 Jul;41(1):61-7. | ||||||||||
| Title: | Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon gamma. | ||||||||||
| Author: | Bateman, W J|Donnellan, I|Fraser, I A|Wong, L S|Morris, A G | ||||||||||
| PMID: | 7641220 | ||||||||||
| 6. | |||||||||||
| Journal: | Nat Immun. 1995 Apr;14(4):188-97. | ||||||||||
| Title: | Human intestinal V delta 1+ T cells obtained from patients with colon cancer respond exclusively to SEB but not to SEA. | ||||||||||
| Author: | Maeurer, M|Zitvogel, L|Elder, E|Storkus, W J|Lotze, M T | ||||||||||
| PMID: | 8696008 | ||||||||||
| 7. | |||||||||||
| Journal: | Cancer Epidemiol Biomarkers Prev. 1997 Jan;6(1):37-48. | ||||||||||
| Title: | Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials. | ||||||||||
| Author: | Einspahr, J G|Alberts, D S|Gapstur, S M|Bostick, R M|Emerson, S S|Gerner, E W | ||||||||||
| PMID: | 8993796 | ||||||||||
| 8. | |||||||||||
| Journal: | World J Surg. 2018 May 23. pii: 10.1007/s00268-018-4684-9. | ||||||||||
| Title: | Analysis of Potential Alterations Affecting SETBP1 as a Novel Contributing Mechanism to Inhibit PP2A in Colorectal Cancer Patients. | ||||||||||
| Author: | Torrejon, Blanca|Cristobal, Ion|Carames, Cristina|Prieto-Potin, Ivan|Chamizo, Cristina|Santos, Andrea|Sanz-Alvarez, Marta|Serna-Blasco, Roberto|Luque, Melania|Madoz-Gurpide, Juan|Rojo, Federico|Garcia-Foncillas, Jesus | ||||||||||
| PMID: | 29796729 | ||||||||||